OUR VISION
To be a global leader in precision medicine by revolutionizing and understanding the use of AI in personalized gene therapies, and making the commercially available to individuals globally.
AI
We leverage the latest AI technologies to analyze vast and complex genomic data. By using personalized algorithms, our platform will processes genetic information faster and with greater precision, allowing us to uncover new insights into human health and diseases.
Genomic Data
We work with large-scale datasets from verified sources, combining the power of AI with trusted genomic data. This enables us to explore new possibilities in human DNA, identifying critical genetic markers that can lead to breakthroughs in understanding diseases.
Treatment
Our focus is on discovering treatments for previously untreatable autoimmune diseases. By applying advanced technologies and genomic insights, we aim to create personalized therapies that address complex genetic disorders and bring new hope to patients.
COMMUNITY
COMING SOON
ABOUT US
Tim Szalay, Founder, CEO
At 12, I was diagnosed with JIA (Juvenile Idiopathic Arthritis), and was told by many doctors that there was no cure. Rather than accept that, I turned my passion toward challenging the limits of medicine. This led me to computer and data science, where I discovered tools that could transform how we treat diseases. I founded ABYA Genomics to harness AI and big data, aiming to bring hope to those facing conditions once thought untreatable.
Zoltan Halasz, Co-founder, CTO
As the head of a project in the field of personalized medicine, which, according to medical experts, has achieved significant success in the realms of medicine and AI, my only limitation in completing projects successfully has been my own imagination. However, rather than being a hindrance, it has always been a challenge to overcome. At this time, there is no better opportunity to harness the potential of collected data than to apply it in practice for research purposes, utilizing the most advanced AI systems.